← 返回

脐带血 NK 细胞来源外泌体通过靶向 ROS 介导的线粒体功能障碍抑制胰腺癌进展

英文原题:Exosomes derived from umbilical cord blood NK cells inhibit the progression of pancreatic cancer by targeting ROS-mediated mitochondrial dysfunction.

查看英文原题

Exosomes derived from umbilical cord blood NK cells inhibit the progression of pancreatic cancer by targeting ROS-mediated mitochondrial dysfunction.

PubMed 2025/04/29(内容时间) Saudi Pharm J Q2 · IF 4.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

新兴研究表明,自然杀伤(NK)细胞来源外泌体(NK-exo)在癌症发生发展中发挥重要作用。然而,其调控机制,特别是在胰腺癌中的机制,仍未得到充分阐明。

本研究采用体外共培养系统和体内皮下肿瘤模型,评估NK-exo对胰腺癌的抗肿瘤作用。脐带血(UCB)来源NK-exo呈现典型外泌体形态、大小和标志物表达,并可被PANC-1细胞摄取。NK-exo以显著且剂量依赖的方式降低细胞增殖、迁移和侵袭(P<0.01)。

进一步分析显示,NK-exo通过改变活性氧(ROS;P<0.0001)和线粒体膜电位(MPP;P<0.0001),诱导PANC-1细胞发生线粒体凋亡;N-乙酰半胱氨酸(NAC)处理可显著减弱上述效应(P<0.0001)。

此外,NK-exo处理的PANC-1细胞中,凋亡标志物Caspase3(P<0.0001)和Caspase9(P=0.0086)上调;qRT-PCR显示PGC-1α(P=0.0064)、TFAM(P<0.0001)和SOD2(P=0.0021)释放减少。蛋白质印迹分析显示,总Caspase3、Caspase9、Bax和细胞色素c水平呈显著剂量依赖性升高,而抗凋亡蛋白Bcl-2下降。动物实验进一步证实,NK-exo处理可显著降低肿瘤体积和重量,并提高相较于肿瘤模型组的Bax蛋白表达。这些发现表明,NK-exo可通过内吞进入PANC-1细胞,诱导线粒体氧化损伤并抑制PANC-1细胞进展,从而产生强效抗胰腺癌作用。

展开英文摘要原文

Emerging research indicates that natural killer (NK) cell-derived exosomes (NK-exo) play a significant role in cancer development.

However, their regulatory mechanisms, particularly in pancreatic cancer, remain poorly elucidated.

This study employed an in vitro co-culture system and an in vivo subcutaneous tumor model to evaluate the anti-tumor effect of NK-exo on pancreatic cancer. Umbilical cord blood (UCB)-derived NK-exo displayed characteristic exosomal morphology, size, and marker expression and was internalized by PANC- 1 cells. NK-exo significantly and dose-dependently reduce cell proliferation, migration, and invasion (P < 0. 01).

Further analysis demonstrated that NK-exo induced mitochondrial apoptosis in PANC- 1 cells by altering reactive oxygen species (ROS, P < 0. 0001) and mitochondrial membrane potential (MPP) levels (P < 0. 0001), effects that were significantly diminished with N-acetylcysteine (NAC) treatment (P < 0. 0001).

Furthermore, NK-exo treated PANC- 1 cells showed upregulation of the apoptotic markers Caspase3 (P < 0. 0001) and Caspase9 (P = 0. 0086) and reduced the release of PGC- 1 (P = 0. 0064), TFAM (P < 0. 0001), and SOD2 (P = 0. 0021) as demonstrated by qRT-PCR.

Western blot analyses revealed a dose dependent significant elevation of total Caspase3, Caspase9, Bax, and cytochrome c level and depression in the anti-apoptotic Bcl- 2. Animal experiments further confirmed that NK-exo treatment significantly reduced tumor volume and weight and increased Bax protein expression relative to the tumor model group.

These findings indicate that NK-exo can enter PANC- 1 cells via endocytosis, induce mitochondrial oxidative damage, and suppress PANC- 1 cell progression, thereby demonstrating a robust anti-pancreatic cancer effect.

论文信息

作者
Zheng Y、Zou X、Li Q、Jiang D、Zhu F、Wu Y
第一作者单位
School of Life Science, Jining Medical University, Rizhao City, Shandong, China.China
通讯作者单位
School of Life Science, Jining Medical University, Rizhao City, Shandong, China. yqwu@mail.jnmc.edu.cn.China
期刊
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2025 Apr 29
原文标识
PubMed 40397293 · DOI 10.1007/s44446-025-00009-3